Skip to content

AMSMNQ

L'imagerie personnalisée par la médecine nucléaire

Accueil
Mission
- Mission de l’AMSMNQ
- Mission du Comité de DPC de l’AMSMNQ
Qui Sommes Nous ?
Guide de Pratique
Journaux
Organisations
Partenaires
Accès DPC
Nous Joindre

Search for:

Prix Sanofi-Genzyme

Posted on 18 juin 20156 juillet 2019 by admin

Prix AMSMNQ
Colloque 2014 en Photos
Colloque 2015 en Photos
Colloque 2016 en Photos
Colloque 2017 en Photos
Colloque 2018 en Photos
Colloque 2019 en Photos
Automnales

Congrès et Colloque à venir

JNM en Primeur

Genetic determinants of pheochromocytoma and paraganglioma imaging phenotypes 20 mars 2020
A Prospective, Comparative Study of Planar and Single-photon Emission Computed Tomography Ventilation/Perfusion Imaging for Chronic Thromboembolic Pulmonary Hypertension 20 mars 2020
11C-PABA as a Novel PET Radiotracer for Functional Renal Imaging: Preclinical and First-in-Human Studies 20 mars 2020
Benefit of improved performance with state-of-the art digital PET/CT for lesion detection in oncology 20 mars 2020
Molecular imaging in the era of precision medicine: paraganglioma as a template for understanding multiple levels of analysis 20 mars 2020
18F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria 20 mars 2020
Confirmation of 123I-FP-CIT-SPECT (ioflupane) quantification methods in dementia with Lewy body and other neurodegenerative disorders 20 mars 2020
The optimal imaging window for dysplastic colorectal polyp detection using c-Met targeted fluorescence molecular endoscopy 20 mars 2020
OpenDose: open access resources for nuclear medicine dosimetry 13 mars 2020
68Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients 13 mars 2020
Kinetic modeling and test-retest reproducibility of 11C-EKAP and 11C-FEKAP, novel agonist radiotracers for PET imaging of the kappa opioid receptor in humans 13 mars 2020
Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in HER2-negative Breast Cancer 13 mars 2020
Neuroendocrine Differentiation and Response toPSMA-Targeted Radioligand Therapy in Advanced Metastatic Castration-Resistant Prostate Cancer: a Single-Center Retrospective Study 13 mars 2020
Prognostic Value of 18F-FDG PET/CT in a Large Cohort of 495 Patients with Advanced Metastatic Neuroendocrine Neoplasms (NEN) Treated with Peptide Receptor Radionuclide Therapy (PRRT) 13 mars 2020
Moving towards multicenter therapeutic trials in ALS: feasibility of data pooling using different TSPO positron emission tomography (PET) radioligands. 13 mars 2020

Info-Lettre AMSMNQ

Email

Statistiques du Site

Utilisateurs en ligne: 1
Today's Visitors: 1
Yesterday's Visitors: 2
Total Visitors: 104 740

Facebook AMSMNQ

Translate »